Cargando…
Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats
INTRODUCTION: Doxorubicin (DOX) is a well-known anticancer drug. However its clinical use has been limited due to cardiotoxic effects. One of the major concerns with DOX therapy is its toxicity in patients who are frail, particularly diabetics. Several studies suggest that mesenchymal stem cells (MS...
Autores principales: | Ammar, Hania Ibrahim, Sequiera, Glen Lester, Nashed, Mira B., Ammar, Rasha I., Gabr, Hala M., Elsayed, Hany E., Sareen, Niketa, Rub, Ejlal Abu-El, Zickri, Maha B., Dhingra, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546321/ https://www.ncbi.nlm.nih.gov/pubmed/26296856 http://dx.doi.org/10.1186/s13287-015-0142-x |
Ejemplares similares
-
Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells
por: Abu-El-Rub, Ejlal, et al.
Publicado: (2019) -
Graphene Oxide-Gold Nanosheets Containing Chitosan Scaffold Improves Ventricular Contractility and Function After Implantation into Infarcted Heart
por: Saravanan, Sekaran, et al.
Publicado: (2018) -
Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior
por: Sareen, Niketa, et al.
Publicado: (2018) -
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
por: Shoukry, Heba Samy, et al.
Publicado: (2017) -
Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells
por: Abu-El-Rub, Ejlal, et al.
Publicado: (2020)